Allergic Rhinoconjunctivitis: Clinical Trials

2 trials for Allergic Rhinoconjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Allergic Rhinoconjunctivitis: new trials by email Literature Review of Allergic Rhinoconjunctivitis trials Research Report on Allergic Rhinoconjunctivitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
MM09-MG01(30.000-30.000), MG01(30.000), MM09(30.000) - Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis
Phase 3TerminatedInmunotek S.L.182021-04-302023-12-19
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
Sublingual allergy immunological tablet, Placebo - Allergic Rhinoconjunctivitis
Phase 3TerminatedALK-Abelló A/S802019-11-042022-06-30

Narrower conditions

Conjunctivitis, Allergic (1)  ·  Dust Mite Allergy (1)  ·  Hypersensitivity (1)  ·  Rhinitis, Allergic (1)  ·  Rhinitis, Allergic, Perennial (1)  ·  Rhinitis, Allergic, Seasonal (1)

Broader conditions

Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Nose Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Respiratory Hypersensitivity (2)  ·  Respiratory Tract Diseases (2)  ·  Rhinitis (2)  ·  Conjunctival Diseases (1)  ·  Conjunctivitis (1)  ·  Eye Diseases (1)  ·  Hypersensitivity (1)  ·  Rhinitis, Allergic (1)

Sponsors

ALK-Abelló A/S (1)  ·  Inmunotek S.L. (1)

Countries

Austria (1)  ·  China (1)  ·  Spain (1)

Top investigators

Ana Isabel Tabar Purroy, MD; PhD (1)  ·  Luo Zhang, Prof. (1)

NIH funding

2018 (1)